טוען...
Resistance of Cancer Cells to Targeted Therapies Through the Activation of Compensating Signaling Loops
The emergence of low molecular weight kinase inhibitors as “targeted” drugs has led to remarkable advances in the treatment of cancer patients. The clinical benefits of these tumor therapies, however, vary widely in patient populations and with duration of treatment. Intrinsic and acquired resistanc...
שמור ב:
| Main Authors: | , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Bentham Science Publishers
2013
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4095943/ https://ncbi.nlm.nih.gov/pubmed/25045345 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1574362409666140206221931 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|